Search research articles
Contact Us
Filters
Showing results (111-120 of 129) with videos related to
Page
of 13
Sort By:
The Medical Journal of Australia
|
July 26, 1980
Prediction of response to antihypertensive therapy with prazosin
E P MacCarthy, G W Frost, J C Monaghan, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
January 1, 1978
Comparative haemodynamic effects of clonidine and guanfacine
H F Oates, L M Stoker, E P MacCarthy, et al.
The Journal of Experimental Medicine
|
February 1, 1974
Renal hypertension in rats immunized against angiotensin I and angiotensin II
H F Oates, G S Stokes, B G Storey, et al.
Progress in Biochemical Pharmacology
|
January 1, 1988
An Na+-K+-ATPase inhibitor which circulates in renal failure but not in essential hypertension
G S Stokes, L A Norris, J F Marwood, et al.
The Medical Journal of Australia
|
May 15, 1995
Diet modification in lowering plasma cholesterol levels. A randomised trial of three types of intervention
H J Johnston, M Jones, G Ridler-Dutton, et al.
The Medical Journal of Australia
|
September 7, 1974
Bartter's syndrome presenting during pregnancy: results of amiloride therapy
G S Stokes, B S Andrews, E Hagon, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1990
Timing of blood pressure measurements in determining anomalies in duration of effect of an antihypertensive drug: assessment of isradipine
G S Stokes, G M Shenfield, H J Johnston, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 1994
Genotypic influence on plasma dipeptidyl carboxypeptidase-1 activity in hypertensives
B J Morris, J C Monaghan, R Perich, et al.
Australian and New Zealand Journal of Medicine
|
June 27, 2000
Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity
G S Stokes, J C Monaghan, A P Schrader, et al.
British Medical Journal
|
November 27, 1976
Prazosin: the first-dose phenomenon
R M Graham, I R Thornell, J M Gain, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 129) with videos related to
Sort By:
Page
of 13
The Medical Journal of Australia
|
July 26, 1980
Prediction of response to antihypertensive therapy with prazosin
E P MacCarthy, G W Frost, J C Monaghan, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
January 1, 1978
Comparative haemodynamic effects of clonidine and guanfacine
H F Oates, L M Stoker, E P MacCarthy, et al.
The Journal of Experimental Medicine
|
February 1, 1974
Renal hypertension in rats immunized against angiotensin I and angiotensin II
H F Oates, G S Stokes, B G Storey, et al.
Progress in Biochemical Pharmacology
|
January 1, 1988
An Na+-K+-ATPase inhibitor which circulates in renal failure but not in essential hypertension
G S Stokes, L A Norris, J F Marwood, et al.
The Medical Journal of Australia
|
May 15, 1995
Diet modification in lowering plasma cholesterol levels. A randomised trial of three types of intervention
H J Johnston, M Jones, G Ridler-Dutton, et al.
The Medical Journal of Australia
|
September 7, 1974
Bartter's syndrome presenting during pregnancy: results of amiloride therapy
G S Stokes, B S Andrews, E Hagon, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1990
Timing of blood pressure measurements in determining anomalies in duration of effect of an antihypertensive drug: assessment of isradipine
G S Stokes, G M Shenfield, H J Johnston, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 1994
Genotypic influence on plasma dipeptidyl carboxypeptidase-1 activity in hypertensives
B J Morris, J C Monaghan, R Perich, et al.
Australian and New Zealand Journal of Medicine
|
June 27, 2000
Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity
G S Stokes, J C Monaghan, A P Schrader, et al.
British Medical Journal
|
November 27, 1976
Prazosin: the first-dose phenomenon
R M Graham, I R Thornell, J M Gain, et al.
Page
of 13